Autopsy report · NCT05073172

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

“study staff transition”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

OHSU Knight Cancer Institute

Sponsor type

University, hospital or other

Conditions

Breast Carcinoma; Head and Neck Carcinoma; Radiation-Induced Dermatitis

Interventions

Calendula Ointment; Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment; Polyethylene Glycol Hydrogel; Silicone-based Film Forming Topical Gel; Silver Sulfadiazine; Topical Hydrocortisone

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation
  “Change in study personnel.” (70% match in meaning)
• Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
  “Personnel changes at study site.” (68% match in meaning)
• A Clinical Trial for CTD-ILD Treatment
  “Departure of study team” (67% match in meaning)
• Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
  “Limited staff to carry out study” (65% match in meaning)
• Transcutaneous Intercostal Nerve Stimulation in Spinal Cord Injury
  “Lack of study staff” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.